The Role of Nontuberculous Mycobacteria in Patients With Cystic Fibrosis Advanced Lung Disease
{{output}}
Background: Despite decreased morbidity and mortality in patients with cystic fibrosis (CF) with CFTR modulators, a significant percentage still develop advanced lung disease. Nontuberculous mycobacteria (NTM) remain challenging ... ...
